Top-News

Ampliphi Biosciences News

Keine aktuellen Kursdaten verfügbar
WKN: A1JH7T
ISIN: US03211P1030
Typ: Aktie

Ampliphi Biosciences News

18.11.21 - PR Newswire
Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs
Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs Announces FDA clearance ...
04.11.21 - PR Newswire
Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress
Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress -- Company to Present at Global Gathering of Infectious Disease Leaders and Investors -- ...
28.10.21 - PR Newswire
Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals
Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals Funds to be used to further advance development of lead candidate AP-PA02, which is being ...
07.07.21 - PR Newswire
Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference PR Newswire
27.01.21 - PR Newswire
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs PR Newswire
09.12.20 - PR Newswire
Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors
Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors Biogen Chief Accounting Officer adds significant financial leadership experience PR ...
27.04.08 - Hugin
Targeted Genetics Announces Data From First Gene Therapy Trial forLeber's Congenital Amaurosis in New England Journal of Medicine
Phase 1/2 Data Shows Improvement in Visual Function   FORT LAUDERDALE, FL and SEATTLE, WA--(Marketwire - April 27, 2008) - Targeted Genetics Corporation (NASDAQ ...
14.06.07 - Hugin
Targeted Genetics Reports Inflammatory Arthritis Clinical Data atEuropean Rheumatology Conference
BARCELONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- June 14, 2007 -- Targeted Genetics Corporation (NASDAQ: TGEN) today is reporting data from the dose escalation arm ...
01.05.07 - Hugin
University College London, Moorfields Eye Hospital and TargetedGenetics Initiate Phase I/II Clinical Trial of Gene Therapy forChildhood Blindness
LONDON and SEATTLE, WA -- (MARKET WIRE) -- May 01, 2007 -- University College London's (UCL) Institute of Ophthalmology, Moorfields Eye Hospital and Targeted Genetics ...
14.12.01 - Aktiencheck
Targeted Genetics "buy" - Wachovia Securities
30.11.01 - Aktiencheck
Target Genetics "strong buy" - Ladenburg Thalmann

Newssuche

Videos

newspaper
08:50 Uhr
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »